Who owns TELOMIR PHARMACEUTICALS INC?
- Ticker: TELO
- CUSIP Number: 87975f104
Tip: Access positions for across all investors
Analyze quarterly positions in Telomir Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Telomir Pharmaceuticals stock
Who bought or sold TELOMIR PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Capital Management | 1.6M | $2.1M | 62% | Jun 2026 |
|
| Geode Capital Management | 339k | $434k | 36% | Jun 2026 |
|
| BlackRock | 281k | $359k | -3% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 225k | $288k | 66% | Jun 2026 |
|
| Northern Trust | 62k | $79k | 47% | Jun 2026 |
|
| State Street Corporation | 59k | $76k | 0% | Mar 2026 |
|
| Bank of New York Mellon | 52k | $66k | 0% | Jun 2026 |
|
| Captrust Financial Advisors | 51k | $66k | 100% | Jun 2026 |
|
| Advisor Group Holdings | 42k | $53k | 16% | Jun 2026 |
|
| Pensionmark Financial Group | 37k | $48k | 0% | Jun 2026 |
|
| Resources Investment Advisors | 23k | $29k | 0% | Jun 2026 |
|
| Qube Research & Technologies | 22k | $28k | 100% | Jun 2026 |
|
| Praetorian Wealth Management | 20k | $26k | 0% | Jun 2026 |
|
| Virtu Financial | 18k | $22k | 100% | Jun 2026 |
|
| Vestmark Advisory Solutions | 14k | $17k | 4% | Jun 2026 |
|
| Citadel Advisors | 13k | $17k | 100% | Jun 2026 |
|
| Morton Capital Management | 13k | $16k | 0% | Jun 2026 |
|
| Two Sigma Securities | 13k | $16k | 100% | Jun 2026 |
|
| Hartland & Co | 13k | $16k | 0% | Jun 2026 |
|
| Wealth Enhancement Advisory Services | 12k | $0 | 100% | Jun 2026 |
|
| NorthCrest Asset Manangement | 12k | $15k | 100% | Jun 2026 |
|
| Kestra Private Wealth Services | 11k | $14k | 0% | Jun 2026 |
|
| Regions Bank | 11k | $14k | 0% | Jun 2026 |
|
| UBS Group | 8.0k | $10k | -14% | Jun 2026 |
|
| Tower Research Capital | 7.9k | $10k | 100% | Jun 2026 |
|
| Vanguard Global Advisers | 6.6k | $8.4k | 0% | Jun 2026 |
|
| Royal Bank of Canada | 754.00 | $1.0k | 100% | Jun 2026 |
|
| Jones Financial Companies, L.L | 600.00 | $744.000000 | 0% | Jun 2026 |
|
| Barclays | 553.00 | $708.005900 | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 201.00 | $256.998600 | -2% | Jun 2026 |
|
| Jpmorgan Chase & Co | 121.00 | $150.995900 | 100% | Jun 2026 |
|
| SBI Securities | 4.00 | $5.000000 | 0% | Jun 2026 |
|
Who sold out of Telomir Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Mar 2026 | 129k | $168k |
| Suncoast Equity Management | Mar 2026 | 51k | $67k |
| XTX Topco | Mar 2026 | 36k | $47k |
| Goldman Sachs Group | Mar 2026 | 10k | $14k |